Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Home Test for Measuring Plasma P-tau217 in Alzheimer's Disease Using Tasso Lancet Device

NCT06622135 is registered in ClinicalTrials.gov with Insight Research Institute as lead sponsor.

NCT NCT06622135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06622135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Home Test for Measuring Plasma P-tau217 in Alzheimer's Disease Using Tasso Lancet Device
Lead sponsor
Insight Research Institute
Phase
Not applicable
Overall status
Terminated
Start date
September 19, 2024
Completion date
December 7, 2024
Enrollment
16 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, healthy subjects